Ascendis Health (JSE:ASC) Change In Receivables : R0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Change In Receivables?

Ascendis Health's change in receivables for the quarter that ended in Jun. 2023 was R0 Mil. It means Ascendis Health's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Ascendis Health's change in receivables for the fiscal year that ended in Jun. 2023 was R5 Mil. It means Ascendis Health's Accounts Receivable declined by R5 Mil from Jun. 2022 to Jun. 2023 .

Ascendis Health's Accounts Receivable for the quarter that ended in Jun. 2023 was R224 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ascendis Health's Days Sales Outstanding for the six months ended in Jun. 2023 was 53.99.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ascendis Health's liquidation value for the six months ended in Jun. 2023 was R47 Mil.

Ascendis Health Change In Receivables Historical Data

The historical data trend for Ascendis Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Change In Receivables Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Get a 7-Day Free Trial

6.42

108.85

73.27

-62.60

4.64

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Ascendis Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0 Mil.

Ascendis Health (JSE:ASC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ascendis Health's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	224.322	/	758.223	*	91
=	53.99

2. In Ben Graham's calculation of liquidation value, Ascendis Health's accounts receivable are only considered to be worth 75% of book value:

Ascendis Health's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	104.078	-	407.814	+	0.75 * 224.322	+	0.5 * 365.938
=	47

Ascendis Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.